BonettiP., LermanL., LermanA.Endothelial dysfunction: a marker of atheresclerotic risk.Arterioscler Thromb Vasc Biol2003; 23: 168–75.
2.
GearingA.J., NewmanW.Circulating adhesion molecules in disease.Immunol Today1993; 14: 506–12.
3.
BonominiM., RealeM., SantarelliP., StuardS., SettefratiN., AlbertazziA.Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients.Nephron1998; 79: 399–407.
4.
van de KerkhofJ., SchalkwijkC.G., KoningsC.J., CheriexE.C., van der SandeF.M., SchefferP.G.Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.Nephrol Dial Transplant2004; 19: 910–6.
5.
MalyszkoJ., MalyszkoJ.S., MysliwiecM.Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.Kidney Blood Press Res2004; 27: 71–7.
6.
PannekeetM.M., ImholzA.L., StruijkD.G., KoomenG.C., LangedijkM.J., SchoutenN.The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients.Kidney Int1995; 48: 866–75.
7.
SmitW., StruijkD.G., Ho-Dac-PannekeetM.M., KredietR.T.Quantification of free water transport in peritoneal dialysis.Kidney Int2004; 66: 849–54.
8.
HoekF.J., KorevaarJ.C., DekkerF.W., BoeschotenE.W., KredietR.T.Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level.Nephrol Dial Transplant2007; 22: 1633–8.
9.
ZemelD., ImholzA.L., de WaartD.R., DinklaC., StruijkD.G., KredietR.T.Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD.Kidney Int1994; 46: 1422–30.
